[ Back to EurekAlert! ]

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Aspirin tablets

Caption: Researchers at Duke Medicine have solved some of the mysteries related to the use of aspirin, and developed a blood-based test of gene activity that has been shown to accurately identify who will respond to the therapy and who is at higher risk for heart attack.

Credit: Duke Medicine

Usage Restrictions: None

Related news release: Biomarker predicts heart attack risk based on response to aspirin therapy


[ Back to EurekAlert! ]